T regulatory cell separation for clinical application.

T regulatory cell separation for clinical application.

Item
http://www.wikidata.org/entity/Q38026324
Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull miceUtilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.Thinking out of the box--new approaches to controlling GVHD.Treg therapy in transplantation: a general overview.Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host Disease.Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.The NOTCH1/CD39 axis: a Treg trip-switch for GvHD.NOTCH and Graft-Versus-Host Disease
P2860

T regulatory cell separation for clinical application.

Item
http://www.wikidata.org/entity/Q38026324
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
T regulatory cell separation for clinical application.
@en
type
label
T regulatory cell separation for clinical application.
@en
prefLabel
T regulatory cell separation for clinical application.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
T regulatory cell separation for clinical application
@en
P2093
P304
P31
P356
10.1016/J.TRANSCI.2012.06.007
P433
P478
P50
P577
P698